معرفی
Professor John O'Brien is a leading academic in neurodegenerative diseases at Newcastle University, specializing in dementia research, particularly Alzheimer's and Lewy body dementia. His work focuses on biomarker development, neuroimaging techniques, and clinical diagnosis. He has contributed to consensus guidelines for dementia management and led studies on plasma biomarkers, polygenic risk, and diagnostic criteria for Lewy body disorders.
Research interests include neuroimaging applications (MRI/SPECT), clinical symptom analysis, and the pathophysiological mechanisms underlying cognitive decline. His team explores plasma metabolites, cholinergic pathways, and white matter changes as diagnostic tools. Collaborations span global institutions, addressing clinical challenges such as disease staging and patient care optimization.
Recent studies highlight advancements in distinguishing dementia subtypes via biomarkers and genetic profiling. He has authored over 150 publications, emphasizing translational research to improve diagnostic accuracy and therapeutic strategies.